(Q46819537)

25 December 2017

title

Effect of etanercept on insulin sensitivity in nine patients with psoriasis (English)

1 reference

25 December 2017

1 reference

M Marra

1

1 reference

25 December 2017

A Campanati

2

1 reference

25 December 2017

R Testa

3

1 reference

25 December 2017

C Sirolla

4

1 reference

25 December 2017

A R Bonfigli

5

1 reference

25 December 2017

C Franceschi

6

1 reference

25 December 2017

F Marchegiani

7

1 reference

25 December 2017

A Offidani

8

1 reference

25 December 2017

publication date

1 October 2007

1 reference

25 December 2017

International Journal of Immunopathology and Pharmacology

published in

1 reference

25 December 2017

volume

20

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

731-736

1 reference

25 December 2017

Banting lecture 1988. Role of insulin resistance in human disease

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

Is type II diabetes mellitus a disease of the innate immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

Inflammation: the link between insulin resistance, obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

Effects of etanercept in patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

Interleukin-6-174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200702000408

10.1177/039463200702000408

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

18179745

1 reference

25 December 2017